Fig. 9From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical resultsRegression of recalsitrant cyctoid macular edema after the WJ-MSC application (Table 1, patient no.16: left eye)Back to article page